CAPLIN POINT LABORATORIES
Quarterly Results Analysis [Jun2024]
CAPLIN POINT LABORATORIES Quarterly Results
Consolidated | Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹459 Cr | ₹453 Cr | ₹436 Cr | ₹410 Cr | ₹395 Cr | ₹389 Cr | ₹372 Cr | ₹359 Cr |
Expenses | ₹307 Cr | ₹308 Cr | ₹293 Cr | ₹273 Cr | ₹269 Cr | ₹265 Cr | ₹263 Cr | ₹253 Cr |
Operating Income | ₹152 Cr | ₹145 Cr | ₹142 Cr | ₹137 Cr | ₹127 Cr | ₹124 Cr | ₹109 Cr | ₹106 Cr |
Other Income | ₹19 Cr | ₹17 Cr | ₹17 Cr | ₹20 Cr | ₹12 Cr | ₹11 Cr | ₹14 Cr | ₹16 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹16 Cr | ₹16 Cr | ₹14 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Profit Before Tax | ₹154 Cr | ₹146 Cr | ₹145 Cr | ₹146 Cr | ₹127 Cr | ₹124 Cr | ₹112 Cr | ₹110 Cr |
Profit After Tax | ₹125 Cr | ₹121 Cr | ₹120 Cr | ₹116 Cr | ₹104 Cr | ₹101 Cr | ₹97 Cr | ₹92 Cr |
EPS | ₹16.31 | ₹16.01 | ₹15.43 | ₹15.12 | ₹13.62 | ₹13.45 | ₹12.84 | ₹12.09 |
Industry Peers & Returns | 1W | 1M | 1Y |
CAPLIN POINT LABORATORIES | -2% | -6.7% | 72.6% |
SUN PHARMACEUTICAL INDUSTRIES | -0.6% | 1.3% | 65.7% |
CIPLA | -2.3% | -6.8% | 33.8% |
DR REDDYS LABORATORIES | 1.5% | 1% | 22.9% |
ZYDUS LIFESCIENCES | -4.2% | -8.1% | 72.3% |
DIVIS LABORATORIES | -1.1% | 11.4% | 64% |
MANKIND PHARMA | -4% | 9.3% | 51.6% |
TORRENT PHARMACEUTICALS | -2.9% | -1.6% | 85.6% |
LUPIN | -2.1% | -4.1% | 84.5% |
CAPLIN POINT LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.27 % |
Y-o-Y | 16.10 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2024 | ₹459 Cr | 1.27 | |
Mar2024 | ₹453 Cr | 4.07 | |
Dec2023 | ₹436 Cr | 6.20 | |
Sep2023 | ₹410 Cr | 3.73 | |
Jun2023 | ₹395 Cr | 1.55 | |
Mar2023 | ₹389 Cr | 4.63 | |
Dec2022 | ₹372 Cr | 3.63 | |
Sep2022 | ₹359 Cr | - |
CAPLIN POINT LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 4.53 % |
Y-o-Y | 19.98 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2024 | ₹152 Cr | 4.53 | |
Mar2024 | ₹145 Cr | 2.07 | |
Dec2023 | ₹142 Cr | 3.55 | |
Sep2023 | ₹137 Cr | 8.59 | |
Jun2023 | ₹127 Cr | 2.10 | |
Mar2023 | ₹124 Cr | 13.31 | |
Dec2022 | ₹109 Cr | 3.59 | |
Sep2022 | ₹106 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 3.25 % |
Y-o-Y | 3.34 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2024 | 33.08% | 3.25 | |
Mar2024 | 32.04% | -1.93 | |
Dec2023 | 32.67% | -2.51 | |
Sep2023 | 33.51% | 4.69 | |
Jun2023 | 32.01% | 0.53 | |
Mar2023 | 31.84% | 8.30 | |
Dec2022 | 29.4% | -0.03 | |
Sep2022 | 29.41% | - |
CAPLIN POINT LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 3.08 % |
Y-o-Y | 19.92 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2024 | ₹125 Cr | 3.08 | |
Mar2024 | ₹121 Cr | 1.14 | |
Dec2023 | ₹120 Cr | 3.25 | |
Sep2023 | ₹116 Cr | 11.41 | |
Jun2023 | ₹104 Cr | 2.96 | |
Mar2023 | ₹101 Cr | 3.88 | |
Dec2022 | ₹97 Cr | 5.80 | |
Sep2022 | ₹92 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 1.76 % |
Y-o-Y | 3.26 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2024 | 27.21 % | 1.76 | |
Mar2024 | 26.74 % | -2.80 | |
Dec2023 | 27.51 % | -2.79 | |
Sep2023 | 28.3 % | 7.40 | |
Jun2023 | 26.35 % | 1.39 | |
Mar2023 | 25.99 % | -0.69 | |
Dec2022 | 26.17 % | 2.11 | |
Sep2022 | 25.63 % | - |
CAPLIN POINT LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 1.87 % |
Y-o-Y | 19.75 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2024 | ₹16.31 | 1.87 | |
Mar2024 | ₹16.01 | 3.76 | |
Dec2023 | ₹15.43 | 2.05 | |
Sep2023 | ₹15.12 | 11.01 | |
Jun2023 | ₹13.62 | 1.26 | |
Mar2023 | ₹13.45 | 4.75 | |
Dec2022 | ₹12.84 | 6.20 | |
Sep2022 | ₹12.09 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD